Muhammad Ali

Muhammad Ali

Peter Maccallum Cancer Centre - Melbourne / Australia
Medical and Health Sciences / Radiation Oncology
AD Scientific Index ID: 5309688
-
person_outline Muhammad Ali's MOST POPULAR ARTICLES
1-) 5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK (the International …S Siva, M Ali, RJM Correa, A Muacevic, L Ponsky, RJ Ellis, SS Lo, ...The Lancet Oncology 23 (12), 1508-1516, 2022532022
2-) The role of stereotactic ablative body radiotherapy in renal cell carcinomaM Ali, J Mooi, N Lawrentschuk, RR McKay, R Hannan, SS Lo, WA Hall, ...European urology 82 (6), 613-622, 2022362022
3-) Efficacy of nivolumab in a patient with metastatic renal cell carcinoma and end‐stage renal disease on dialysis: case report and literature reviewJ Ansari, M Ali, A Farrag, AM Ali, A AlhamadCase Reports in Immunology 2018 (1), 1623957, 2018342018
4-) Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trialS Siva, M Bressel, M Sidhom, S Sridharan, BGL Vanneste, R Davey, ...The Lancet Oncology 25 (3), 308-316, 2024332024
5-) Stereotactic body radiotherapy for primary renal cell carcinoma: a systematic review and practice guideline from the International Society of Stereotactic Radiosurgery (ISRS)S Siva, AV Louie, R Kotecha, MN Barber, M Ali, Z Zhang, M Guckenberger, ...The Lancet Oncology 25 (1), e18-e28, 2024252024